Novel microtubule-based hypothesis for frontontemporal dementia leading to therapy for military personnel and veterans
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110189
- Recipient
-
Drexel University UEI XF3XM9642N96
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $302,750
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from USAspending.gov.
About this award
Drexel University was awarded a $302,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop a novel microtubule-based hypothesis for frontotemporal dementia leading to potential therapies for military personnel and veterans. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions applicable to battlefield health and beyond. Drexel University will conduct research that could further the program's goals of investigating medical solutions for service members and investigating frontotemporal dementia, a condition that sometimes affects veterans.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $302,750 |
Quick answers
Who received award W81XWH2110189?
W81XWH2110189 was awarded to Drexel University by Defense Health Agency (Department of Defense) on March 15, 2021.
How much is award W81XWH2110189 worth?
$302,750 has been obligated on W81XWH2110189.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award